Additional filtering of blood from a cell salvage device is not likely to show important additional benefits in outcome in cardiac surgery

Abstract

Several authors and manufacturers of cell salvage devices recommend additional filtering of processed blood before transfusion. There is no evidence to support this practice. Therefore, we compared the clinical outcome and biochemical effects of cell salvage with or without additional filtering.